Letrohope 2.5 Tablet
  1. Home
  2. Pharma Products
  3. Mankind Pharma Ltd
  4. Letrohope 2.5 Tablet

Letrohope 2.5 Tablet

Letrohope 2.5 Tablet contains letrozole 2.5 mg, an aromatase inhibitor used in hormone-sensitive breast cancer. It is mainly used to treat breast cancer in postmenopausal women. The tablet is taken orally as prescribed by a healthcare professional.

BUY NOW

Category

Letrozole works by reducing estrogen production, which can help slow the growth of estrogen-dependent breast cancer cells. It may be used for early or advanced breast cancer according to the prescribed treatment plan. Long-term treatment may require monitoring of bone health and other clinical parameters because reduced estrogen levels can affect bone mineral density and cholesterol levels. The dosage and treatment duration are individualized by the treating physician based on the patient’s condition and response to therapy.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 5 Tablets
Manufacturer / Marketer Mankind Pharma Ltd

Product Also Known As

Letrohope 2.5 Tablet, Letrohope 2.5mg Tablet, Letrohope 2.5 Tablet, Letrozole 2.5 mg Tablet, Letrozole 2.5mg Tablet, Letrozole Oral Tablet, Letrozole Breast Cancer Tablet